Rehabilitation and MS-Centre Overpelt, Belgium



Similar documents
Riga Centre of Psychiatry and Addiction Medicine, Latvia

German Social Accident Insurance, DGUV, Germany

Groupe MGEN - Mutuelle Générale de l'education Nationale, France

Entidade Reguladora da Saúde ERS (Portuguese Health Regulatory Authority), Portugal

German Mesothelioma Register

Ministère des Affaires Sociales et de la Santé, France

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES

Board of Member States ERN implementation strategies

Policy proposals to improve access to multiple sclerosis treatments in Europe

Rehabilitation Medicine Programme

MS IN EUROPE Overview of the

Neurorehabilitation Strategy Briefing Document and Position Paper

ENS4Care Questionnaire

Estate Planning and Patients' Rights in Cross-Border Healthcare

COMMISSION OF THE EUROPEAN COMMUNITIES

EURORDIS Position Paper on Centres of Expertise and European Reference Networks for Rare Diseases

Third EU Health Programme

IMPROVING YOUR EXPERIENCE

MS-NEED: Multiple Sclerosis-Nurse Empowering Education

EPF Position Statement on the European Commission s proposal for a Regulation on In Vitro Medical Devices

Good Scientific Practice

No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008

The EFPIA Disclosure Code: Your Questions Answered

Nursing Knowledge for Your Benefit

Employment, Social policy, Health and Consumer affairs Council meeting Brussels, 1 December 2014

The European regulatory system for medicines and the European Medicines Agency

Alzheimer s Australia Submission on the Draft Report of the Productivity Commission Inquiry into Disability Care and Support

HIC 2009 Workshop Introduction to Health Informatics

Acting Together: How to continue to provide high quality and universally accessible health services in a financially sustainable way in Europe.

WHO Consultation on the Zero Draft Global Mental Health Action Plan International Diabetes Federation (IDF) Submission

ehealth in support of safety, quality and continuity of care within and across borders

ADULT HEALTH AND WELLBEING LONG-TERM NEUROLOGICAL CONDITIONS

Third EU Health Programme

CALL FOR QUOTATION For COMMUNICATION SERVICES

Main Specialty/Treatment Function Codes. Human Behavioural Guidance

BOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC FAX

Maximising Ability, Reducing Disability. Dr. Áine Carroll Clinical Lead Valerie Twomey Programme Manager

SSNAP s Acute Organisational Audit Report 2012: Performance Summary for South London

EUROPEAN COMMISSION HIGH LEVEL PROCESS OF REFLECTION ON PATIENT MOBILITY AND HEALTHCARE

Advancing Healthcare through Information Technology and Management Systems

CEN and CENELEC response to the EC Consultation on Standards in the Digital Single Market: setting priorities and ensuring delivery January 2016

Adult Neuromuscular pathway (Dec 2014) (18 years onwards)

The new EU Clinical Trials Regulation How NHS research and patients will benefit

Future hospital: Caring for medical patients. Extract: Recommendations

Advanced Nurse Practitioner Specialist. Palliative

Skill Levels for Delivering High Quality Asthma and COPD Respiratory Care by Nurses in Primary Care

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a RECOMMENDATION OF THE COUNCIL AND OF THE EUROPEAN PARLIAMENT

Self Care in New Zealand

Introduction Assessment Tools... 2

Advanced Nurse Practitioner Adult Specialist Palliative Care

Profile: Kessler Patients

Eurojust s Multi-annual. Strategic Plan Organisational developments. Centre of expertise. Operational work. Partners

Written Contribution of the National Association of Statutory Health Insurance Funds of

Today s Health Research Is Tomorrow s Healthcare

Agence fédérale des médicaments et des produits de santé

National Clinical Programmes

Feasibility Study for a EU Pension Fund for Researchers. European Commission Research Directorate-General

Regulatory approval routes in the European System for Medicinal Products

Abt Associates Inc. Abt Associates Clinical Trials Comprehensive clinical research services

Commissioning Policy (EMSCGP005V2) Defining the boundaries between NHS and Private Healthcare

Neurological Rehabilitation in Practice

COURSE APPROVAL GUIDELINES APS COLLEGE OF HEALTH PSYCHOLOGISTS

Corl Kerry - Referral and Assessment for Residential Treatment (Tier 4) Introduction Types of Tier 4 Services Services provided at Tier 4

Supervision and delegation framework for allied health assistants

THE ORGANISATION AND FINANCING OF HEALTH CARE SYSTEM IN LATVIA

About the consultation

How To Manage Health Care Needs

Better pathways for people with aphasia. available evidence and guidelines (Kwan et al., 2004). A care pathway can further be described as a

Transcription:

Rehabilitation and MS-Centre Overpelt, Belgium 1.1 Please indicate the type of organisation on behalf of which you are responding to this consultation: Please indicate what type: 1. Respondent Profile Healthcare provider Hospital Please indicate for what the administration is responsible: 1.1.1. Other (please specify): Specialized institution for rehabilitation of neurological diseases, including coma, and specialized institution for diagnosis, treatment, follow-up and research on Multiple Sclerosis (MS) 1.2 Please indicate the name of your organisation or centre: Rehabilitation and MS-Centre Overpelt 1.3 Please indicate the country where your organsation/centre is located/has its headquarters or main representative office in Europe: 1. Please indicate the number of EU Member States and EEA countries (rway, Iceland, Lichtenstein) and accessing country (Croatia) in which your organisation conducts business/is represented: 1. If need be, can we contact you by e-mail to obtain further information on your submission? 1..1 Please provide an e-mail address where we can contact you: bart.vanwijmeersch@uhasselt.be and patric.groenen@msreva.be BE 1 1.6 Please provide us with a contact person (incl jobtitle and daytime phone number): Patric Groenen General Director Boemerangstraat 2 B-3900 Overpelt Belgium 0032-11-809101

1.7 Please provide additional contact details if needed: 2. Involvement of your organisation in the matter of centres of excellence/reference (COE) and healthcare networks in highly specialised healthcare (HSHC). 2.1 How would you describe your organisation's knowledge of CoE and HSHC? 2.1.1 Space for further comments: 2.2. What aspects or domains related to the topic of CoE and HSHC would correspond to your organisation's key knowledge? (cross any that applies) n applicable Highly specialised healthcare provision Professional performance, clinical practice, quality and safety of specialized healthcare 2.2.1. Space for further comments: Specialized in the total care of MS and the specific rehab of coma patients (and neurological disorders). For MS research is done with Hasselt University, therefore we might be regarded as CoE in MS. 2.3 Is highly specialised healthcare a priority in your organisation's strategies and work plans? 2.3.1 Space for further comments: 2.. What specific field of healthcare services/specialities are most relevant for your centre/organisation's field of work? Very high Medical speciality Please specify: 2.. Has your organisation/centre been directly involved in the design or assessment of professional standards and criteria related with highly specialised healthcare? MS: total care, research Coma: rehab Frequently

2..1 Please describe your role in such actions/projects: We are recognized as an Expert Centre on Coma rehab and Reference Centre for MS: we develop criteria for MS-Centres in Belgium and guidelines for MS-treatment and multidisciplinary approach 2.6. Has your organisation been involved in projects/activities supported by the Commission in relation with HSHC or professional and technical criteria/standards in highly specialised healthcare? 2.7. Do you have concrete examples based on your own organisation's experience or could you provide us with references or links to documents related with professional criteria and standards in highly specialised healthcare/coe or HSHC (e.g. quality criteria, guidelines, consensus documents)? 2.7.1 Space for further comments: Mainly based on our own experience, since we are taking part in initiatives to further develop reference centers for Multiple Sclerosis in Belgium 2.8. Is your centre or unit directly involved in the management (diagnosis, treatment etc.) of highly specialised diseases or conditions? 2.9. Is your centre or unit designated or recognised as centre of reference/excellence in your country? 2.10. How has your centre been designated/recognised as centre of reference/excellence? Other 2.10.1 Space for further comments: Formal recognition as well as recognition based on professional grounds

2.11. Which is your area of expertice as centre of reference? (please provide your answer in free text) 2.12 Is your centre participating currently in a network of centres of expertise? 2.13. What is the scope of the network? Regional 1. Expertise on MS: diagnosis, treatment, follow-up, multidisciplinary rehab, fundamental/clinical research, training, education. 2. Expertise on rehab of Coma patients (after stay on ICU) 2.1. Which kind of network? National 2.1.1 Space for further comments: 2.1. Would you be interested in applying to the process to be considered Centre of Excellence of the future European Reference Network? (1 = not interested at all, = very interested) 2.1.1 Space for further comments: Especially for Multiple Sclerosis we believe that our Centre (and affiliation with Hasselt University) has every aspect of a European CoE. For standard of care for MS patients as well as for research 3. Proposed criteria for ERN (scope, general and specific criteria) 3.1 Criteria related with diseases or conditions in order to be considered under the scope of the ERN 3.1.1. Need of highly specialised healthcare 3.1.1.1. Complexity of the diagnosis and treatment 3.1.1.2. High cost of treatment and resources

3.1.1.3. Need of advanced/highly specialised medical equipment or infrastructures 3.1.2. Need of particular concentration of expertise and resources 3.1.2.1. Rare expertise/need of concentration of cases 3.1.2.2. Low prevalence/incidence/number of cases 3.1.2.3. Evaluated experiences of Member States 3 3.1.3. Based on high-quality, accessible and cost-effective healthcare 3.1.3.1. Evidence of the safety and favourable risk-benefit analysis 3.1.3.2. Feasibility and evidence of the value and potential positive outcome (clinical) 3.1.. Do you recommend any additional criteria or option that would effectively address the issue? 3.1.. Would you prioritise or suggest any concrete disesase or group of diseases to be addressed by the future ERN according to the above criteria? 3.1..1 Explain your proposal in free text: Multiple Sclerosis is the best example of a disease to organize a ERN for. Needs multidisciplinary care. Research and expertise is present in Europe, but big differences in patient care possibilities 3.2. General criteria of the centres wishing to join a European Reference Network 3.2.1. Organisation and management

3.2.2. Patients empowerment and centered care 3.2.3. Patient care, clinical tools and health technology assessment 3.2.. Quality, patient safety and evaluation framework policies 3.2.. Business continuity, contingency planning and response capacity 3.2.6. Information systems, technology and e-health tools and applications 3.2.7. Overall framework and capacity for research and training 3.2.8. Specific commitment of the management/direction of the centre/hospital to ensure a full and active participation in the ERN 3.2.9. Do you recommend any additional option that would effectively address the issue? 3.2.9.1. Space for further comments: research possibilities, high quality, patient centered care are the most important criteria 3.3. Specific criteria regarding the areas of expertise 3.3.1. Competence, experience and good outcomes and care 3.3.2. Specific resources and organisation: 3 3.3.2.1. Human resources 3 3.3.2.2. Team/centre organisation

3.3.2.3. Structural conditions 3 3.3.2.. Specific equipment 3.3.2.. Presence and coordination with other required complementary units or services 3.3.3. Patient care pathways, protocols and clinical guidelines in the field of expertise 3.3.. External coordination, care management and follow-up of patients 3.3.. Research, training, health technology assessment in the field of expertise 3.3.6. Specific information systems 3.3.7. Do you recommend any additional criteria or option that would effectively address the issue? 3.3.7.1. Space for further comments: possibility of multidisciplinary team based care is important, with good clinical pathways and research based medicine (evidence based medicine)